Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 97

Report ID: 19616

Inflammatory bowel disease (IBD) is a broad term used to describe disorders involving chronic inflammation of digestive tract. The disease is categorized by severe diarrhea, abdominal pain, fatigue, and weight loss.
Increase in incidences of IBD and rise in adoption of anti-inflammatory drugs drive the market. In addition, strong upcoming pipeline of IBD drugs also boosts the market growth. However, side effects of these drugs over a patients body restrain the market growth. Development of biosimilars for existing drugs, and growth opportunities in the emerging economies of Asia-Pacific and LAMEA provide opportunities for the market growth.
In 2018, the global Inflammatory Bowel Disease (IBD) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Inflammatory Bowel Disease (IBD) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Inflammatory Bowel Disease (IBD) Therapeutics development in United States, Europe and China.

The key players covered in this study
Abbvie
Johnson & Johnson
GlaxoSmithKline
Merck
Novartis
Celgene
Pfizer
Salix
Roche
Teva Pharmaceutical

Market segment by Type, the product can be split into
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory drugs (NSAIDs)
Corticosteroids

Market segment by Application, split into
Hospital
Research

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Inflammatory Bowel Disease (IBD) Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Inflammatory Bowel Disease (IBD) Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Inflammatory Bowel Disease (IBD) Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Anti-inflammatory Biologics
1.4.3 Non-Steroidal Anti-inflammatory drugs (NSAIDs)
1.4.4 Corticosteroids
1.5 Market by Application
1.5.1 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Research
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Inflammatory Bowel Disease (IBD) Therapeutics Market Size
2.2 Inflammatory Bowel Disease (IBD) Therapeutics Growth Trends by Regions
2.2.1 Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Regions (2014-2025)
2.2.2 Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Manufacturers
3.1.1 Global Inflammatory Bowel Disease (IBD) Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Inflammatory Bowel Disease (IBD) Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Inflammatory Bowel Disease (IBD) Therapeutics Key Players Head office and Area Served
3.3 Key Players Inflammatory Bowel Disease (IBD) Therapeutics Product/Solution/Service
3.4 Date of Enter into Inflammatory Bowel Disease (IBD) Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type (2014-2019)
4.2 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
5.2 Inflammatory Bowel Disease (IBD) Therapeutics Key Players in United States
5.3 United States Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type
5.4 United States Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application

6 Europe
6.1 Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
6.2 Inflammatory Bowel Disease (IBD) Therapeutics Key Players in Europe
6.3 Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type
6.4 Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application

7 China
7.1 China Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
7.2 Inflammatory Bowel Disease (IBD) Therapeutics Key Players in China
7.3 China Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type
7.4 China Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application

8 Japan
8.1 Japan Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
8.2 Inflammatory Bowel Disease (IBD) Therapeutics Key Players in Japan
8.3 Japan Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type
8.4 Japan Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
9.2 Inflammatory Bowel Disease (IBD) Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type
9.4 Southeast Asia Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application

10 India
10.1 India Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
10.2 Inflammatory Bowel Disease (IBD) Therapeutics Key Players in India
10.3 India Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type
10.4 India Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
11.2 Inflammatory Bowel Disease (IBD) Therapeutics Key Players in Central & South America
11.3 Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type
11.4 Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application

12 International Players Profiles
12.1 Abbvie
12.1.1 Abbvie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.1.4 Abbvie Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.1.5 Abbvie Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.2.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.3.4 GlaxoSmithKline Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.4.4 Merck Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.5.4 Novartis Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Celgene
12.6.1 Celgene Company Details
12.6.2 Company Description and Business Overview
12.6.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.6.4 Celgene Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.6.5 Celgene Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.7.4 Pfizer Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.7.5 Pfizer Recent Development
12.8 Salix
12.8.1 Salix Company Details
12.8.2 Company Description and Business Overview
12.8.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.8.4 Salix Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.8.5 Salix Recent Development
12.9 Roche
12.9.1 Roche Company Details
12.9.2 Company Description and Business Overview
12.9.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.9.4 Roche Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.9.5 Roche Recent Development
12.10 Teva Pharmaceutical
12.10.1 Teva Pharmaceutical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.10.4 Teva Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.10.5 Teva Pharmaceutical Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details